Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
I
Ientile, Valentina
Italian National Institute for Nuclear Physics
Impact of data source diversity on the distribution of key variables in pregnancy cohorts based on the ConcePTION pregnancy algorithm leveraging a random forest imputation model
Location:Room XV
Valentina Ientile
Ilomäki, Jenni
Centre for Medicine Use and Safety, Monash University
Use of Gabapentinoids and Risk of Hip Fractures: A Population-based Case-crossover and Case-case-time-control Study
Location:Room II
Jenni Ilomäki
Inacio, Maria
Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
Validity of pharmaceutical claims data for determining medication exposure in long-term care facilities
Location:Room III
Maria Inacio
Ingrasciotta, Ylenia
Department of Diagnostics and Public Health, University of Verona, Verona
Impact of data source diversity on the distribution of key variables in pregnancy cohorts based on the ConcePTION pregnancy algorithm leveraging a random forest imputation model
Location:Room XV
Ylenia Ingrasciotta
Risk of serious infections in psoriasis/psoriatic arthritis biological drug users: a large-scale, propensity score matched cohort study using the Italian VALORE Project distributed database
Location:Room III
Ylenia Ingrasciotta
Switching pattern of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the Italian multi-regional VALORE distributed database network
Location:Room III
Ylenia Ingrasciotta
Pattern of use of biological drugs in pediatric patients with immune-mediated inflammatory diseases through the Italian VALORE distributed database network
Location:Room III
Ylenia Ingrasciotta
How to Design a Real-World Study of Biologics, Including Biosimilars
Location:Room XV
Ylenia Ingrasciotta
Inokuchi, Ryota
University of Tokyo
Screening of drug-related adverse events by sequence symmetry analysis with spline-based self-controlled case-series design for dose-response relationship: a proof of concept study
Location:Conv Hall I D
Ryota Inokuchi
Ishtiak-Ahmed, Kazi
Department of Affective Disorders, Aarhus University Hospital Psychiatry, Aarhus, Denmark
Pharmacogenetic CYP2D6 variability, phenoconversion and treatment outcomes: A Danish population-based cohort study of 6,798 individuals initiating atomoxetine treatment
Location:Room IV
Kazi Ishtiak-Ahmed
Issa, Amalia
Pharmacogenomics, Precision Medicine and Oncology
Location:Room XV
Amalia Issa
Iwagami, Masao
Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
Screening of drug-related adverse events by sequence symmetry analysis with spline-based self-controlled case-series design for dose-response relationship: a proof of concept study
Location:Conv Hall I D
Masao Iwagami
Iwata, Isao
Penn Medicine Princeton Health
Inhaler Utilization Patterns among Medicare Beneficiaries (2008-2020): Towards Sustainable Prescribing Practices in the US
Location:Room IV
Isao Iwata
Iyer, Geetha
Harvard T.H. Chan School of Public Health
Foundations in Causal Inference
Location:Room IV
Geetha Iyer
Iyer, Hari
Rutgers Cancer Institute of New Jersey
Association Between Fine Particulate Matter Exposure During Breast Cancer Treatment And Mortality Among Older Women in the United States
Location:Conv Hall I D
Hari Iyer
Izurieta, Hector
US Food and Drug Administration
Added Benefit and Waning Effectiveness of a Third-Dose mRNA COVID-19 Vaccine in Community-Dwelling Medicare Beneficiaries Aged ≥65 Years in Omicron Period
Location:Conv Hall I C
Hector Izurieta
Innovative Self-controlled Risk Interval Analysis of Effectiveness of COVID-19 mRNA Booster Vaccination in the Veterans Health Administration, Omicron Predominant Period
Location:Conv Hall I C
Hector Izurieta
Intermediate/Advanced Topics in Vaccine Safety and Effectiveness
Location:Auditorium
Hector Izurieta
